Bifurcation

The Abdominal Aortic Aneurysm Market to Boost at a CAGR of 3% During the Study Period (2019-32), Assesses DelveInsight

Retrieved on: 
Monday, May 2, 2022

LAS VEGAS, May 2, 2022 /PRNewswire/ -- DelveInsight's Abdominal Aortic Aneurysm Market Insights report includes a comprehensive understanding of current treatment practices, Abdominal Aortic Aneurysm emerging treatment devices, market share of therapy classes, and current and forecasted market size from 2019 to 2032, segmented into 7MM (the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), and Japan.

Key Points: 
  • The majority of Abdominal Aortic Aneurysm grow slowly without noticeable Abdominal Aortic Aneurysm symptoms.
  • The Abdominal aortic aneurysm ultrasound and Abdominal aortic aneurysm CT scan are among the most commonly used tools for Abdominal aortic aneurysm diagnosis.
  • The Abdominal Aortic Aneurysm Market Report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
    There are currently no Abdominal Aortic Aneurysm drugs available to slow the growth of Abdominal Aortic Aneurysm.
  • Moreover, the growing geriatric population and Abdominal Aortic Aneurysm incidence in Western countries present a profitable opportunity for the Abdominal Aortic Aneurysm market.

Global Influential Clinical Body Exclusively Endorses Mentice Cardiology Bifurcation Simulation

Retrieved on: 
Monday, February 28, 2022

The endorsement is unique for Mentice patented VIST G7+ Coronary Advanced training module that provides an approved patient-free learning environment for Interventional Cardiologists in the field of bifurcation stenting.

Key Points: 
  • The endorsement is unique for Mentice patented VIST G7+ Coronary Advanced training module that provides an approved patient-free learning environment for Interventional Cardiologists in the field of bifurcation stenting.
  • All virtual proctor-led steps in the Coronary Advanced bifurcation procedures are based on the EBC consensus and strictly follow their guidelines.
  • The EBC's technical standardization of bifurcation stenting is derived from the annual consensus among experts and KOLs within the field of Interventional Cardiology.
  • Promotion of education and training, and continuous refinement of bifurcation stenting techniques represent a major clinical need.

Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval

Retrieved on: 
Tuesday, January 12, 2021

The WEB System is a unique, single-device treatment solution for wide neck bifurcation aneurysms in a new category of devices called intrasaccular flow disruptors.

Key Points: 
  • The WEB System is a unique, single-device treatment solution for wide neck bifurcation aneurysms in a new category of devices called intrasaccular flow disruptors.
  • When placed inside the aneurysm sac, the WEB device's proprietary microbraid technology bridges the aneurysm neck, disrupting blood flow, and creates a scaffold for long-lasting treatment.
  • "The excellent clinical results we can achieve with intrasaccular flow disruption technology has changed the way we approach the treatment of wide neck bifurcation aneurysms, and the WEB 17 System expands upon that.
  • When placed inside the aneurysm sac, the WEB device's proprietary microbraid technology bridges the aneurysm neck, disrupting blood flow, and creates a scaffold for long-lasting treatment.

North America Aromatherapy Market Worth $1,639.9 Million by 2030, says P&S Intelligence

Retrieved on: 
Thursday, December 17, 2020

The rising incidence of such lifestyle-associated diseases is expected to propel the North American aromatherapy market from $763.7 million in 2019 to $1,639.9 million by 2030, at a 7.6% CAGR between 2020 and 2030, according to P&S Intelligence.

Key Points: 
  • The rising incidence of such lifestyle-associated diseases is expected to propel the North American aromatherapy market from $763.7 million in 2019 to $1,639.9 million by 2030, at a 7.6% CAGR between 2020 and 2030, according to P&S Intelligence.
  • The consumables bifurcation, on the basis of product, generated the higher revenue in the North American aromatherapy market in the past.
  • Presently, the larger share in the North American aromatherapy market, under the distribution channel segment, is held by the indirect bifurcation.
  • P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world.

North America Aromatherapy Market Worth $1,639.9 Million by 2030, says P&S Intelligence

Retrieved on: 
Thursday, December 17, 2020

The rising incidence of such lifestyle-associated diseases is expected to propel the North American aromatherapy market from $763.7 million in 2019 to $1,639.9 million by 2030, at a 7.6% CAGR between 2020 and 2030, according to P&S Intelligence.

Key Points: 
  • The rising incidence of such lifestyle-associated diseases is expected to propel the North American aromatherapy market from $763.7 million in 2019 to $1,639.9 million by 2030, at a 7.6% CAGR between 2020 and 2030, according to P&S Intelligence.
  • The consumables bifurcation, on the basis of product, generated the higher revenue in the North American aromatherapy market in the past.
  • Presently, the larger share in the North American aromatherapy market, under the distribution channel segment, is held by the indirect bifurcation.
  • P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world.